XCellAssay

Funding and NIH signals

• NIH award NIH awarded $1.14M (SBIR Phase II 2R44ES036049-02, competing renewal, notice Jul 10, 2026). NIH RePORTER 2R44ES036049-02 (Jul 10, 2026)
  Evidence (1 event)

  • Jul 10, 2026 · NIH RePORTER 2R44ES036049-02
    Organization: XCELLASSAY, INC.; City/State: SAN FRANCISCO, CA; Project number: 2R44ES036049-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-10; FY total cost (award amount): 1135244; Administering IC: National Institute of Environmental Health Sciences; Project title: Multiplexed Nuclear Receptor BioAssay platform to inexpensively and broadly survey the nation's water supply for contamination by endocrine disrupting chemicals; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals